Statistics for Adverum Biotechnologies (id:6848 ADVM)

Valuation metrics

Market cap

150.82M

Enterprise value

77.29M

Trailing P/E (ttm)

-0.52

Forward P/E

-1.36

PEG ratio

-1.36

Price/Sales (ttm)

150.82

Price/Book (mrq)

1.05

Enterprise Value/Revenue

77.29

Enterprise Value/EBITDA

-0.78

Overview

Shares outstanding

20.80M

Float

12.59M

Shares short

1.60M

% Held by insiders

0.12%

% Held by institutions

0.85%

Average volume (10 days)

169.02K

Average volume (90 days)

Price summary

52-Week low

5.69

52-Week high

29.70

52-Week change

-40.50%

Beta

1.01

50-Day moving average

7.47

200-Day moving average

10.24

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

March 21th, 2024

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

0.00%

Operating margin

-2,922.10%

Operational effectiveness

Return on assets

-29.83%

Return on equity

-76.26%

Income statement

Revenue (ttm)

0.06

Revenue per share (ttm)

0.06

Quarterly revenue growth (yoy)

Gross profit (ttm)

0.00

EBITDA

-99,024,000.00

Net income to common (ttm)

-94,111,000.00

Diluted EPS (ttm)

-5.95

Quarterly earnings growth (yoy)

Balance sheet

Total cash (mrq)

153.24M

Total cash per share (mrq)

7.37

Total debt (mrq)

73.26M

Total Debt/Equity (mrq)

50.84

Current ratio (mrq)

582.40%

Book value per share (mrq)

6.93

Cash flow

Cash flow statement

-85,541,000.00

Levered free cash flow (LFCF)

-47,602,500.00